Industry | 2016.05.07
DrugDev President and CEO Ibraheem “Ibs” Mahmood Named to The Medicine Maker International Power 100, Honored as Tech Disruptor by the Philadelphia Business Journal
Recognized for transforming the clinical trials industry by promoting collaboration, standardization and a beautiful technology experience for sponsors, CROs, investigators and patients.
(PRWeb May 06, 2016)
Read the full story at http://www.prweb.com/releases/2016/05/prweb13396788.htm
For more information, please visit
http://www.prweb.com/releases/2016/05/prweb13396841.htm
